Affordable Access

deepdyve-link
Publisher Website

A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.

Authors
  • Liang, Ji-An
  • Sun, Li-Min
  • Lin, Ming-Chia
  • Chang, Shih-Ni
  • Sung, Fung-Chang
  • Muo, Chih-Hsin
  • Kao, Chia-Hung
Type
Published Article
Journal
The Oncologist
Publisher
Alphamed Press
Publication Date
Jan 01, 2012
Volume
17
Issue
7
Pages
986–991
Identifiers
DOI: 10.1634/theoncologist.2011-0464
PMID: 22723508
Source
Medline
License
Unknown

Abstract

This population-based nested case-control study suggested that finasteride use may increase prostate and overall cancer risks for patients with BPH. The effects were more prominent for patients using lower doses of finasteride.

Report this publication

Statistics

Seen <100 times